Intrasense extends its range of offer to expand its market potential, relying on its strong technological innovation capacity.

Intrasense, Harvard and Zhejiang (China) teaching hospitals are pleased to be finalists for the Galien - MedStartup 2017 Award.

Intrasense announces a new European patent, for invention of a technology facilitating clinician's diagnostic work-up.

Intrasense announces its 2016 results.

Intrasense announces the signature at RSNA of two contracts in the USA and one in the Middle East.

Intrasense announces its presence at RSNA 2016 where it will unveil its new Myrian® 2.0 version.

Intrasense announces its half-year results until June, 30 2016 as approved by the Board of Directors on October 24, 2016.

Intrasense is happy to announce its participation to MedStartup Program 2016, organized by Galien Fundation and Business France.

Intrasense annonces the issuance of a second tranche of "OCABSA" by Bracknor Funds Ltd for a total amount of €1,000,000.

The nomination of Olivier Marrot and Eric Le Bihan as independent board members has been approved during June 28, 2016 shareholders' meeting.